{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:13:45Z","timestamp":1790644425846,"version":"4.1.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016391","name":"Societat Catalana de Digestologia","doi-asserted-by":"publisher","award":["2015 Research Initiation Grant #3"],"award-info":[{"award-number":["2015 Research Initiation Grant #3"]}],"id":[{"id":"10.13039\/501100016391","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joan Bruguera Fund","award":["Girona Townhall, 2017"],"award-info":[{"award-number":["Girona Townhall, 2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42368-4","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:33:35Z","timestamp":1772775215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary insights into gut microbiome shifts as screening proxy for MASLD disease progression"],"prefix":"10.1038","volume":"16","author":[{"given":"M. Llir\u00f3s","family":"Dupr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bux\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Virol\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pujolassos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lluans\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bah\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Aldeguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"42368_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-0035-1562942","volume":"35","author":"A Burt","year":"2015","unstructured":"Burt, A., Lackner, C. & Tiniakos, D. Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification. Semin Liver Dis. 35, 207\u2013220 (2015).","journal-title":"Semin Liver Dis."},{"key":"42368_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"(EASD) E. A. for the S. of D","year":"2024","unstructured":"(EASDE) A for the S. of D. & et al. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492\u2013542 (2024).","journal-title":"J. Hepatol."},{"key":"42368_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults. Lancet 384, 755\u2013765 (2014).","journal-title":"Lancet"},{"key":"42368_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"(EASL), E. A. for the S. of the L., (EASD), E. A. for the S. of D. & (EASO), E. A. for the S. of O.","year":"2016","unstructured":"(EASL), E. A. for the S. of the L., (EASD), E. A. for the S. of D. & (EASO), E. A. for the S. of O. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388\u20131402 (2016).","journal-title":"J. Hepatol."},{"key":"42368_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","volume":"55","author":"H Hu","year":"2020","unstructured":"Hu, H. et al. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. J. Gastroenterol. 55, 142\u2013158 (2020).","journal-title":"J. Gastroenterol."},{"key":"42368_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong, R. J. et al. Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States. Gastroenterology 148, 547\u2013555 (2015).","journal-title":"Gastroenterology"},{"key":"42368_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42368_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh, T. G. et al. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell. Metab. 32, 878\u2013888e6 (2020).","journal-title":"Cell. Metab."},{"key":"42368_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","volume":"22","author":"L Caballer\u00eda","year":"2010","unstructured":"Caballer\u00eda, L. et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur. J. Gastroenterol. Hepatol. 22, 24\u201332 (2010).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"42368_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372\u2013384 (2010).","journal-title":"J. Hepatol."},{"key":"42368_CR11","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Prim. 1, 15080 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"42368_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 149, 389\u2013397e10 (2015).","journal-title":"Gastroenterology"},{"key":"42368_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"42368_CR14","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62, S47\u2013S64 (2015).","journal-title":"J. Hepatol."},{"key":"42368_CR15","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 71, 1851\u20131864 (2020).","journal-title":"Hepatology"},{"key":"42368_CR16","doi-asserted-by":"publisher","first-page":"eabf8271","DOI":"10.1126\/science.abf8271","volume":"376","author":"BS Gosis","year":"2022","unstructured":"Gosis, B. S. et al. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science 376, eabf8271 (2022).","journal-title":"Science"},{"key":"42368_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/microorganisms11082059","volume":"11","author":"Z. Li","year":"2023","unstructured":"Li, Z., Yuan, H., Chu, H. & Yang, L. The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease. Microorganisms 11, 2059 (2023).","journal-title":"Microorganisms"},{"key":"42368_CR18","first-page":"216","volume":"5","author":"R Kumar","year":"2017","unstructured":"Kumar, R. & Mohan, S. Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications. J. Clin. Transl Hepatol. 5, 216\u2013223 (2017).","journal-title":"J. Clin. Transl Hepatol."},{"key":"42368_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim, D. & Kim, W. R. Nonobese Fatty Liver Disease. Clin. Gastroenterol. Hepatol. 15, 474\u2013485 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"42368_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M. & Trauner, M. Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives. Hepatology 65, 350\u2013362 (2017).","journal-title":"Hepatology"},{"key":"42368_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"42368_CR22","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","volume":"11","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk, A. A., Zheng, D., Shibolet, O. & Elinav, E. The role of the microbiome in NAFLD and NASH. EMBO Mol. Med. 11, e9302 (2019).","journal-title":"EMBO Mol. Med."},{"key":"42368_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 17, 279\u2013297 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42368_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo, P. et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846\u2013854 (2007).","journal-title":"Hepatology"},{"key":"42368_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","volume":"58","author":"MV Machado","year":"2013","unstructured":"Machado, M. V. & Cortez-Pinto, H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J. Hepatol. 58, 1007\u20131019 (2013).","journal-title":"J. Hepatol."},{"key":"42368_CR26","doi-asserted-by":"publisher","first-page":"16820","DOI":"10.3748\/wjg.v20.i45.16820","volume":"20","author":"S Sharma","year":"2014","unstructured":"Sharma, S., Khalili, K. & Nguyen, G. C. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J. Gastroenterol. 20, 16820\u201316830 (2014).","journal-title":"World J. Gastroenterol."},{"key":"42368_CR27","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","volume":"21","author":"Y Lurie","year":"2015","unstructured":"Lurie, Y., Webb, M., Cytter-Kuint, R., Shteingart, S. & Lederkremer, G. Z. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J. Gastroenterol. 21, 11567\u201311583 (2015).","journal-title":"World J. Gastroenterol."},{"key":"42368_CR28","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1038\/s41467-023-40328-4","volume":"14","author":"J Boursier","year":"2023","unstructured":"Boursier, J. et al. Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests. Nat. Commun. 14, 5219 (2023).","journal-title":"Nat. Commun."},{"key":"42368_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka, A. C. et al. Nonalcoholic Steatohepatitis JAMA 323, 1175\u20131183 (2020).","journal-title":"Nonalcoholic Steatohepatitis JAMA"},{"key":"42368_CR30","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","volume":"2","author":"J Halfvarson","year":"2017","unstructured":"Halfvarson, J. et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat. Microbiol. 2, 17004 (2017).","journal-title":"Nat. Microbiol."},{"key":"42368_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature23889","volume":"550","author":"J Lloyd-Price","year":"2017","unstructured":"Lloyd-Price, J. et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550, 61\u201366 (2017).","journal-title":"Nature"},{"key":"42368_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"42368_CR33","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3748\/wjg.v25.i18.2149","volume":"25","author":"J Lv","year":"2019","unstructured":"Lv, J. et al. Alteration of the esophageal microbiota in Barrett\u2019s esophagus and esophageal adenocarcinoma. World J. Gastroenterol. 25, 2149\u20132161 (2019).","journal-title":"World J. Gastroenterol."},{"key":"42368_CR34","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F B\u00e4ckhed","year":"2005","unstructured":"B\u00e4ckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-Bacterial Mutualism in the Human Intestine. Science 307, 1915\u20131920 (2005).","journal-title":"Science"},{"key":"42368_CR35","doi-asserted-by":"crossref","unstructured":"Schnupf, P. & Sansonetti, P. J. Shigella pathogenesis: New insights through advanced methodologies. Microbiol. Spectr. 7(2), 1\u201324 (2019).","DOI":"10.1128\/microbiolspec.BAI-0023-2019"},{"key":"42368_CR36","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1038\/s41564-023-01493-w","volume":"8","author":"MA Odenwald","year":"2023","unstructured":"Odenwald, M. A. et al. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat. Microbiol. 8, 2033\u20132049 (2023).","journal-title":"Nat. Microbiol."},{"key":"42368_CR37","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions Between the Microbiota and the Immune System. Science 336, 1268\u20131273 (2012).","journal-title":"Science"},{"key":"42368_CR38","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.2337\/db13-0844","volume":"62","author":"F Karlsson","year":"2013","unstructured":"Karlsson, F., Tremaroli, V., Nielsen, J. & B\u00e4ckhed, F. Assessing the Human Gut Microbiota in Metabolic Diseases. Diabetes 62, 3341\u20133349 (2013).","journal-title":"Diabetes"},{"key":"42368_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/PPO.0000000000000044","volume":"20","author":"L Yang","year":"2014","unstructured":"Yang, L., Chaudhary, N., Baghdadi, J. & Pei, Z. Microbiome in Reflux Disorders and Esophageal Adenocarcinoma. Cancer J. 20, 207\u2013210 (2014).","journal-title":"Cancer J."},{"key":"42368_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.seminoncol.2015.09.005","volume":"43","author":"AG Neto","year":"2016","unstructured":"Neto, A. G., Whitaker, A. & Pei, Z. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma. Semin Oncol. 43, 86\u201396 (2016).","journal-title":"Semin Oncol."},{"key":"42368_CR41","first-page":"1","volume":"2016","author":"F. Li","year":"2016","unstructured":"Li, F., Duan, K., Wang, C., McClain, C. & Feng, W. Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol. Res. Pr. 2016, 1\u201311 (2016).","journal-title":"Gastroenterol. Res. Pr"},{"key":"42368_CR42","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1073\/pnas.0306398101","volume":"101","author":"Z Pei","year":"2004","unstructured":"Pei, Z. et al. Bacterial biota in the human distal esophagus. Proc. Natl. Acad. Sci. 101, 4250\u20134255 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"42368_CR43","first-page":"1392","volume":"131","author":"P Sharma","year":"2006","unstructured":"Sharma, P. et al. The Development and Validation of an Endoscopic Grading System for Barrett\u2019s Esophagus: The Prague. C M Criteria Gastroenterology. 131, 1392\u20131399 (2006).","journal-title":"C M Criteria Gastroenterology"},{"key":"42368_CR44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","volume":"134","author":"RB Sartor","year":"2008","unstructured":"Sartor, R. B. Microbial Influences in Inflammatory Bowel Diseases. Gastroenterology 134, 577\u2013594 (2008).","journal-title":"Gastroenterology"},{"key":"42368_CR45","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016\u20131022 (2009).","journal-title":"Nat. Med."},{"key":"42368_CR46","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","volume":"137","author":"L Yang","year":"2009","unstructured":"Yang, L. et al. Inflammation and Intestinal Metaplasia of the Distal Esophagus Are Associated With Alterations in the Microbiome. Gastroenterology 137, 588\u2013597 (2009).","journal-title":"Gastroenterology"},{"key":"42368_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cmet.2010.07.001","volume":"12","author":"AL Goodman","year":"2010","unstructured":"Goodman, A. L. & Gordon, J. I. Our Unindicted Coconspirators: Human Metabolism from a Microbial Perspective. Cell. Metab. 12, 111\u2013116 (2010).","journal-title":"Cell. Metab."},{"key":"42368_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur, J. C. et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science 338, 120\u2013123 (2012).","journal-title":"Science"},{"key":"42368_CR49","doi-asserted-by":"publisher","first-page":"9862","DOI":"10.1073\/pnas.1307575110","volume":"110","author":"B Hu","year":"2013","unstructured":"Hu, B. et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. 110, 9862\u20139867 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"42368_CR50","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s10620-016-4155-9","volume":"61","author":"EJ Snider","year":"2016","unstructured":"Snider, E. J., Freedberg, D. E. & Abrams, J. A. Potential Role of the Microbiome in Barrett\u2019s Esophagus and Esophageal Adenocarcinoma. Dig. Dis. Sci. 61, 2217\u20132225 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"42368_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2468-1253(16)30086-3","volume":"2","author":"DRF Elliott","year":"2017","unstructured":"Elliott, D. R. F., Walker, A. W., O\u2019Donovan, M., Parkhill, J. & Fitzgerald, R. C. A non-endoscopic device to sample the oesophageal microbiota: a case-control study. Lancet Gastroenterol. Hepatol. 2, 32\u201342 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"42368_CR52","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11552","volume":"489","author":"V Tremaroli","year":"2012","unstructured":"Tremaroli, V. & B\u00e4ckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242\u2013249 (2012).","journal-title":"Nature"},{"key":"42368_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41564-023-01560-2","volume":"9","author":"AS Little","year":"2024","unstructured":"Little, A. S. et al. Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat. Microbiol. 9, 55\u201369 (2024).","journal-title":"Nat. Microbiol."},{"key":"42368_CR54","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier, J. et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63, 764\u2013775 (2016).","journal-title":"Hepatology"},{"key":"42368_CR55","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung, C., Rivera, L., Furness, J. B. & Angus, P. W. The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412\u2013425 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42368_CR56","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba, R. et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell. Metab. 25, 1054\u20131062e5 (2017).","journal-title":"Cell. Metab."},{"key":"42368_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I Rowland","year":"2018","unstructured":"Rowland, I. et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur. J. Nutr. 57, 1\u201324 (2018).","journal-title":"Eur. J. Nutr."},{"key":"42368_CR58","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/gutjnl-2015-309333","volume":"65","author":"M Schaubeck","year":"2016","unstructured":"Schaubeck, M. et al. Dysbiotic gut microbiota causes transmissible Crohn\u2019s disease-like ileitis independent of failure in antimicrobial defence. Gut 65, 225 (2016).","journal-title":"Gut"},{"key":"42368_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","volume":"31","author":"AB Shreiner","year":"2015","unstructured":"Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31, 69\u201375 (2015).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"42368_CR60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":". (EASL), E. A. for the S. of the L., (EASD), E. A. for the S. of D. & (EASO), E. A. for the S. of O.","year":"2016","unstructured":"(EASL), E. A. for the S. of the L., (EASD), E. A. for the S. of D. & (EASO), E. A. for the S. of O. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59, 1121\u20131140 (2016).","journal-title":"Diabetologia"},{"key":"42368_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.medcli.2019.01.030","volume":"153","author":"L Caballeria","year":"2019","unstructured":"Caballeria, L. et al. Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care. Med. Cl\u00ednica (Engl Ed). 153, 169\u2013177 (2019).","journal-title":"Med. Cl\u00ednica (Engl Ed)"},{"key":"42368_CR62","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"(EASL)","year":"2012","unstructured":"(EASL). E. A. for the S. of the L. & (EORTC), E. O. for R. and T. of C. EASL\u2013EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 56, 908\u2013943 (2012).","journal-title":"J. Hepatol."},{"key":"42368_CR63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard, A. et al. FIB\u20104: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46, 32\u201336 (2007).","journal-title":"Hepatology"},{"key":"42368_CR64","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt, E. M., Janney, C. G., Bisceglie, A. M. D., Neuschwander-Tetri, B. A. & Bacon, B. R. Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions. Am. J. Gastroenterol. 94, 2467\u20132474 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"42368_CR65","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53, 810\u2013820 (2011).","journal-title":"Hepatology"},{"key":"42368_CR66","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"42368_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1148\/radiol.2015150619","volume":"276","author":"R. G. Barr","year":"2015","unstructured":"Barr, R. G. et al. Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276, 845\u2013861 (2015).","journal-title":"Radiology"},{"key":"42368_CR68","first-page":"261","volume":"5","author":"MC Cheah","year":"2017","unstructured":"Cheah, M. C., McCullough, A. J. & Goh, G. B. B. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease. J. Clin. Transl Hepatol. 5, 261\u2013271 (2017).","journal-title":"J. Clin. Transl Hepatol."},{"key":"42368_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1574-6941.2009.00671.x","volume":"68","author":"J Furet","year":"2009","unstructured":"Furet, J. et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 68, 351\u2013362 (2009).","journal-title":"FEMS Microbiol. Ecol."},{"key":"42368_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fcimb.2018.00281","volume":"8","author":"M Lopez-Siles","year":"2018","unstructured":"Lopez-Siles, M. et al. Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects. Front. Cell. Infect. Microbiol. 8, 281 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"42368_CR71","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1128\/AEM.66.11.4605-4614.2000","volume":"66","author":"MT Suzuki","year":"2000","unstructured":"Suzuki, M. T., Taylor, L. T. & DeLong, E. F. Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5\u2019-nuclease assays. Appl. Environ. Microbiol. 66, 4605\u20134614 (2000).","journal-title":"Appl. Environ. Microbiol."},{"key":"42368_CR72","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijmm.2014.02.009","volume":"304","author":"M Lopez-Siles","year":"2014","unstructured":"Lopez-Siles, M. et al. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. Int. J. M\u00e9d Microbiol. 304, 464\u2013475 (2014).","journal-title":"Int. J. M\u00e9d Microbiol."},{"key":"42368_CR73","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2012","unstructured":"Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 41, e1\u2013e1 (2012).","journal-title":"Nucleic Acids Res."},{"key":"42368_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3354\/ame01753","volume":"75","author":"A Apprill","year":"2015","unstructured":"Apprill, A., McNally, S., Parsons, R. & Weber, L. Minor revision to V4 region SSU rRNA 806R gene primer greatly increases detection of SAR11 bacterioplankton. Aquat. Microb. Ecol. 75, 129\u2013137 (2015).","journal-title":"Aquat. Microb. Ecol."},{"key":"42368_CR75","doi-asserted-by":"publisher","first-page":"e00009","DOI":"10.1128\/mSystems.00009-15","volume":"1","author":"W Walters","year":"2016","unstructured":"Walters, W. et al. Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys. mSystems 1, e00009\u201315 (2016).","journal-title":"mSystems"},{"key":"42368_CR76","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/1462-2920.13023","volume":"18","author":"AE Parada","year":"2016","unstructured":"Parada, A. E., Needham, D. M. & Fuhrman, J. A. Primers for marine microbiome studies. Environ. Microbiol. 18, 1403\u20131414 (2016).","journal-title":"Environ. Microbiol."},{"key":"42368_CR77","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods. 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"42368_CR78","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLoS ONE. 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"42368_CR79","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938\u20132940 (2017).","journal-title":"Bioinformatics"},{"key":"42368_CR80","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","volume":"35","author":"E Paradis","year":"2018","unstructured":"Paradis, E. & Schliep, K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics 35, 526\u2013528 (2018).","journal-title":"Bioinformatics"},{"key":"42368_CR81","unstructured":"Oksanen, J. et al. Vegan: Community Ecology Package_. R package version 2.6\u201310. at (2025). https:\/\/CRAN.R-project.org\/package=vegan"},{"key":"42368_CR82","unstructured":"Borman, T., Ernst, F. G. M., Shetty, S. A. & Lahti, L. Microbiome analysis \u2022 mia. at https:\/\/microbiome.github.io\/mia\/ (2025)."},{"key":"42368_CR83","first-page":"100388","volume":"4","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. MicrobiotaProcess: A comprehensive R package for deep mining microbiome. Innov 4, 100388 (2023).","journal-title":"Innov"},{"key":"42368_CR84","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12859-023-05205-3","volume":"24","author":"ML Calle","year":"2023","unstructured":"Calle, M. L., Pujolassos, M. & Susin, A. coda4microbiome: compositional data analysis for microbiome cross-sectional and longitudinal studies. BMC Bioinform. 24, 82 (2023).","journal-title":"BMC Bioinform"},{"key":"42368_CR85","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge, S. M. et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 355, i5239 (2016).","journal-title":"BMJ"},{"key":"42368_CR86","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious, S. A. Sample size of 12 per group rule of thumb for a pilot study. Pharm. Stat. 4, 287\u2013291 (2005).","journal-title":"Pharm. Stat."},{"key":"42368_CR87","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","volume":"11","author":"G Lee","year":"2020","unstructured":"Lee, G. et al. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat. Commun. 11, 4982 (2020).","journal-title":"Nat. Commun."},{"key":"42368_CR88","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686\u2013690 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42368_CR89","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin, M. et al. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. Am. J. Gastroenterol. 113, 1649\u20131659 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"42368_CR90","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gutjnl-2019-320490","volume":"69","author":"H Tilg","year":"2020","unstructured":"Tilg, H., Burcelin, R. & Tremaroli, V. Liver tissue microbiome in NAFLD: next step in understanding the gut\u2013liver axis? Gut 69, 1373\u20131374 (2020).","journal-title":"Gut"},{"key":"42368_CR91","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"DP Venegas","year":"2019","unstructured":"Venegas, D. P. et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol. 10, 277 (2019).","journal-title":"Front. Immunol."},{"key":"42368_CR92","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","volume":"29","author":"M Begley","year":"2005","unstructured":"Begley, M., Gahan, C. G. M. & Hill, C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29, 625\u2013651 (2005).","journal-title":"FEMS Microbiol. Rev."},{"key":"42368_CR93","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani, P. D. et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes 56, 1761\u20131772 (2007).","journal-title":"Diabetes"},{"key":"42368_CR94","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0006-3002(56)90148-2","volume":"22","author":"EA Dawes","year":"1956","unstructured":"Dawes, E. A. & Foster, S. M. The formation of ethanol in Escherichia coli. Biochim. Biophys. Acta. 22, 253\u2013265 (1956).","journal-title":"Biochim. Biophys. Acta"},{"key":"42368_CR95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu, L. et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology 57, 601\u2013609 (2013).","journal-title":"Hepatology"},{"key":"42368_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"42368_CR97","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940\u2013947 (2014).","journal-title":"J. Hepatol."},{"key":"42368_CR98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59\u201364 (2014).","journal-title":"Nature"},{"key":"42368_CR99","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","volume":"10","author":"C Caussy","year":"2019","unstructured":"Caussy, C. et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat. Commun. 10, 1406 (2019).","journal-title":"Nat. Commun."},{"key":"42368_CR100","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1038\/s41598-018-26509-y","volume":"8","author":"V Iebba","year":"2018","unstructured":"Iebba, V. et al. Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy. Sci. Rep. 8, 8210 (2018).","journal-title":"Sci. Rep."},{"key":"42368_CR101","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4161\/gmic.27651","volume":"5","author":"S Miquel","year":"2014","unstructured":"Miquel, S. et al. Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes. 5, 146\u2013151 (2014).","journal-title":"Gut Microbes"},{"key":"42368_CR102","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","volume":"1","author":"P Gin\u00e8s","year":"2016","unstructured":"Gin\u00e8s, P. et al. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol. Hepatol. 1, 256\u2013260 (2016).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"42368_CR103","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/gut.2006.111302","volume":"56","author":"M Fraquelli","year":"2007","unstructured":"Fraquelli, M. et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56, 968 (2007).","journal-title":"Gut"},{"key":"42368_CR104","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jhep.2006.11.010","volume":"46","author":"A Kettaneh","year":"2007","unstructured":"Kettaneh, A. et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients. J. Hepatol. 46, 628\u2013634 (2007).","journal-title":"J. Hepatol."},{"key":"42368_CR105","first-page":"836A","volume":"46","author":"D Lucidarme","year":"2007","unstructured":"Lucidarme, D., Forzy, G., Gremaux, V. & Filoche, B. Interobserver reproducibility of liver stiffness measurement by transient elastography (Fibroscan\u00ae). Hepatology 46, 836A\u2013837A (2007).","journal-title":"Hepatology"},{"key":"42368_CR106","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12866-025-04549-5","volume":"26","author":"J. M. de Medina-M\u00e9ndez","year":"2025","unstructured":"Medina-M\u00e9ndez, J. M., Iruzubieta, P., Fern\u00e1ndez-L\u00f3pez, R., Crespo, J. & de Cruz, F. la. Bacterial metabolic signatures in MASLD predicted through gene-centric studies in stool metagenomes. BMC Microbiol. 26, 70 (2025).","journal-title":"BMC Microbiol."},{"key":"42368_CR107","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. 105, 16731\u201316736 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"42368_CR108","doi-asserted-by":"publisher","first-page":"2297815","DOI":"10.1080\/19490976.2023.2297815","volume":"16","author":"DC Fonseca","year":"2024","unstructured":"Fonseca, D. C. et al. Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases. Gut Microbes. 16, 2297815 (2024).","journal-title":"Gut Microbes"},{"key":"42368_CR109","doi-asserted-by":"publisher","first-page":"31143","DOI":"10.1038\/s41598-024-82418-3","volume":"14","author":"Z Bao","year":"2024","unstructured":"Bao, Z. et al. Predicting host health status through an integrated machine learning framework: insights from healthy gut microbiome aging trajectory. Sci. Rep. 14, 31143 (2024).","journal-title":"Sci. Rep."},{"key":"42368_CR110","doi-asserted-by":"publisher","first-page":"eadp5540","DOI":"10.1126\/science.adp5540","volume":"388","author":"S Zhou","year":"2025","unstructured":"Zhou, S. et al. A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite-CerS6-ceramide axis. Sci. (N York NY). 388, eadp5540 (2025).","journal-title":"Sci. (N York NY)"},{"key":"42368_CR111","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1038\/s41467-020-18871-1","volume":"11","author":"O Manor","year":"2020","unstructured":"Manor, O. et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat. Commun. 11, 5206 (2020).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42368-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T01:02:33Z","timestamp":1777251753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42368-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42368"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42368-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"XA is co-founder of GoodGut S.L. a biotech company, now part of HIPRA\u00ae (https:\/\/www.hipra.com), characterising the role of gut microbiome in health and disease. The other authors have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The presented research respected the fundamental principles of the Helsinki Declaration and followed all the aspects covered in the Council of Europe and the Convention on Human Rights and Biomedicine as well as the requirements established by the Spanish and Catalan legislation in the field of biomedical research, data protection and bioethics. All participants signed informed consent in compliance with Spanish data protection law (LO 3\/2018, of December 5th of 2018 on Protection of personal data and digital rights guarantee (LOPDGDD) and published on December 6th 2018). The institutional review board and ethical committee approved the project on April 2016 (project code: 2016.072).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"13493"}}